Skip to content

A clinical trial to study the effect of punarnavashtak kwath in patients with iron deficiency anemia

Clinical evaluation of the efficacy of punnarnavashtak kwath in the management of pandu rog w.s.r. to iron deficiency anaemia - a randomized controlled trial. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068440
Enrollment
60
Registered
2024-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Dr Aniket Purushottam Raut
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients presenting with classical signs and symptoms of Pandu Rog i.e. Panduta, Daurbalya, Aruchi, Aalaysa, Shwas , Hridyaspandan and Gatrashool will be selected . Minimum 4 symptoms from above will be included . 2) Age with age group 18 – 60 yrs. 3) Haemoglobin level - below 12 gm/dl in Female and below 13 gm/dl in Male 4) Serum Ferritin - below 30 ng/ml in Female and below 50 ng/ml in Male 5) Patients will be selected irrespective of Gender , Occupation and Socioeconomic status .

Exclusion criteria

Exclusion criteria: 1) Age less than 18 yrs and more than 60 yrs. 2) Haemoglobin level below 5 gm/dl 3) Pregnant and lactating mother 4) Any Bleeding Disorders e.g. Haematemesis , Bleeding Piles etc. 5) Anaemia other than Iron Deficiency Anaemia . 6) Severe Renal / Hepatic / Cardiac disease 7) Those Patients not willing for trial and not giving written consent .

Design outcomes

Primary

MeasureTime frame
Improvement Hb% 1. Marked Increased greater than or equal to 1.5 gm/dl 2. Moderate Increased by 1 to 1.4 gm/dl 3. Mild Increased by 0.5 to 0.9 gm/dl 4. Poor Increased by 0 to 0.4 gm/dl Improvement Serum Ferritin 1. Marked Increase greater than 3 ng/dl 2. Moderate Increase by 2.1 to 3 ng/dl 3. Mild Increase by 1.1 to 2 ng/dl 4. Poor Increase by 0 to 1 ng/dlTimepoint: 2 months

Secondary

MeasureTime frame
Improvement in subjective parameters such as 1) Panduta ( Pallor ) 2) Daurabalya ( Weakness ) 3) Aruchi ( Anorexia ) 4) Aalaysa ( Inactivity) 5) Shwas (Dyspnoea) 6) Hrudyaspandan (Palpitation) 7) Gatrashula ( Bodyache)Timepoint: 2 months

Countries

India

Contacts

Public ContactAniket Purushottam Raut

Radhakisan Toshniwal Ayurved Mahavidyalaya, Akola

drsadhana.k@gmail.com9422939510

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026